Nephrocare's Subsidiary to Acquire Dialysis Center Assets in Bataan, Philippines
Nephrocare Health Services Limited, through its wholly-owned subsidiary, has entered into a major agreement for the acquisition of assets related to a dialysis center in the Philippines.The transaction involves Nephrocare Health Care Services, Philippines Inc., a step-down wholly-owned subsidiary of Nephrocare Health Services Limited, and Orani Hemodialysis Center Inc.
The parties executed the Asset Transfer Agreement (ATA) on May 12, 2026. Under the terms of the agreement, the subsidiary is acquiring identified assets from Orani Hemodialysis Center Inc. The acquisition pertains to a dialysis center located in Orani, Bataan, Philippines.
The total consideration for the acquired assets has been set at PHP 89,600,000.00 (Eighty-Nine Million Six Hundred Thousand Pesos Only).
Transaction Details
The acquisition is structured as an asset transfer. Key details of the transaction are as follows:
| Particulars | Details |
|---|---|
| Purchaser | Nephrocare Health Care Services, Philippines Inc. (step-down wholly-owned subsidiary of the Company) |
| Seller | Orani Hemodialysis Center Inc. |
| Purpose | Acquisition of the dialysis center assets. |
| Consideration | PHP 89,600,000.00 |
| Special Rights | There are no special rights stipulated in the agreement. |
| Related Party Status | The subsidiary is a step-down wholly owned subsidiary of the Company. The seller is not related. |
| Related Party Transaction | The transaction does not qualify as a related party transaction. |
NEPHROPLUS Stock Price Movement
Nephrocare Health Services Limited shares rallied today, gaining 3.64% in post-market trading. The stock exhibited powerful momentum, hitting its 52-week high of ₹616 and recording a substantial volume of 664,977 shares traded.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.